HGERS
CRNX icon

Householder Group Estate & Retirement Specialist’s Crinetics Pharmaceuticals CRNX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$1K – 1188
2024
Q2 		$1K Buy
+25
New +$1.16K ﹤0.01% 1120

Other funds holding CRNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's CRNX Position: Q3 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Crinetics Pharmaceuticals (CRNX) in Q3 2024, closing a stake of 25 shares — an estimated $1K sold.

Householder Group Estate & Retirement Specialist first reported a position in CRNX in Q2 2024 and held it in 1 quarter. The position peaked at $1K in Q2 2024. 235 funds tracked by Wall St. Rank hold CRNX as of Q3 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Crinetics Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 25 Crinetics Pharmaceuticals shares in Q3 2024, an estimated $1K.
  • Householder Group Estate & Retirement Specialist first reported a position in Crinetics Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's Crinetics Pharmaceuticals position peaked at $1K in Q2 2024.
  • 235 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q3 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q3 2024, filed 18 Oct 2024.